Influence of cilostazol on the course of reparative processes for patients with diabetic trophic ulcers of lower limbs

Authors

DOI:

https://doi.org/10.11603/2414-4533.2017.4.8134

Keywords:

trophic ulcers, diabetic, lectins, cilostazol.

Abstract

The aim of the work: an analysis of motion of reparative processes for patients with diabetic ulcers of feet at application of standard treatment regimen and at addition of it with cilostazol.

Materials and Methods. 60 patients with diabetic trophic ulcers were selected for the research and they were divided into two groups, the one group took cilostazol in the dose of 100 mg two times a day. Lectins research was executed, for its realization collection of tissues was implemented from wounds before and after two and four weeks of treatment. The set of lectins included: Con A – specific to DMan, HPA – to NAcDGal, PNA – to βDGal, LABA – to αLFuc, SBA – to NAcDGal, WGA – to NAcDGlc.

Results and Discussion. Activation of regenerator processes has been already watched on the 14th day of treatment in the group with application of cilostazol. The appearance of carbohydrate determinant in the endothelia of newly formed vessels is the evidence of it, while there were not such expressed displays of regeneration at most preparations of patients from the control group. After 28 days of treatment the growth of expression of carbohydrate determinant in the germinative layer of epidermis, local strengthening of level of exhibiting of specific membrane glycoproteins on collogen fibres were observed in fabrics from the wounds of patients of the second group, that we consider as a statement of reconstruction in the bunches of collogen fibres.

Author Biography

I. R. Terletskyi, Львівська обласна клінічна лікарня

хірургічне відділення №1, лікар-хірург

References

Yazdanpanah, L., Nasiri, M., & Adarvishi S. (2015). Literature review on the management of diabetic foot ulcer. World Journal of Diabetes, 6 (1), 37-53. doi: 10.4239/wjd.v6.i1.37

Herasymchuk, P.O., Pavlyshyn, A.V., & Holovata, T.K. (2013). Porivnialna morfolohichna kharakterystyka hostroi ta khronichnoi rany u khvorykh na syndrom diabetychnoi stopy [Comparative morphological charasteristics of an acute and chronic wound in patients with syndrome of diabetic foot]. Shpytalna khirurhiia – Hospital Surgery, (1), 22-5 [in Ukrainian].

Preima, Kh.I., & Yashchenko, A.M. (2009). Rol hlikokoniuhativ u protsesakh morfohenezu shkiry potomstva na tli hipotyreozu materynskoho orhanizmu [Role of glycoconjugates in the processes of skin morphogenesis in the offspring with underlying maternal organism’s hypothyrosis]. Bukovynskyi Medychnyi Visnyk – Bukovinian Medical Journal, 13 (4), 232-236 [in Ukrainian].

Yashchenko, A.M., Dankevych, L.V., & Lysiuk, O.D. (2012). Rakovye izmeneniya uglevodov pecheni u indutsirovanikh streptozototsinom diabetisheskikh krys [Rat liver carbohydrate alterations in streptozotocin-induced diabetic rats]. Eur. J. Anat., 16 (2), 82-90 [in Russian].

Bedenis, R., Stewart, M., Cleanthis, M., Robless, P., Mikhailidis, D. P., Stansby, G. (2014). Cilostazol for intermittent claudication. Cochrane Database of Systematic Reviews, (10), [003748]. doi: 10.1002/14651858.CD003748.pub4.

Kobza, I.I., Terletskyi, I. R., Verkhola, M.R., Savchenko, A.A., Vykhtiuk, T.I. (2016). Likuvannia patsiientiv z khronichnymy vyrazkamy nyzhnikh kintsivok [Treatment of patients with trophic ulcers of the lower extremities]. Klinichna flebolohiia – Clinical Phlebology, 9 (1), 43-47 [in Ukrainian].

Kobza, I.I., Terletskyi, I.R., Verkhola, M.R., Savchenko, A.A., Yashchenko, A.M. (2016). Rezultaty likuvannia patsiientiv z trofichnymy vyrazkamy nih [Results of treatment of patients with trophic ulcers of feet]. Halytskyi likarskyi visnyk – Galician Medical Journal, 23 (3), 11-14 [in Ukrainian].

de Franciscis, S., Gallelli, L., Battaglia, L., Molinari, V., Montemurro, R., Stillitano, D. M., … Serra, R. (2015). Cilostazol prevents foot ulcers in diabetic patients with peripheral vascular disease. International Wound Journal, 12 (3), 250-253. doi: 10.1111/iwj.12085.

Wada, T., Onogi, Y., Kimura, Y., Nakano, T., Fusanobori, H., Ishii, Y., … , Sasaoka, T. (2013). Cilostazol ameliorates systemic insulin resistance in diabetic db/db mice by suppressing chronic inflammation in adipose tissue via modulation of both adipocyte and macrophage functions. Eur. J. Pharmacol., 707 (3), 120-129. doi: 10.1016/j.ejphar.2013.03.016.

Published

2018-01-15

How to Cite

Terletskyi, I. R. (2018). Influence of cilostazol on the course of reparative processes for patients with diabetic trophic ulcers of lower limbs. Hospital Surgery. Journal Named by L.Ya. Kovalchuk, (4), 78–83. https://doi.org/10.11603/2414-4533.2017.4.8134

Issue

Section

EXPERIENCE OF WORK